ADVANCED VIROLOGY INC.

Biotech · Private

Synthetic RNA viruses produced without cell culture passage to avoid adaptive mutations

Grants
$279K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Low-cost and high efficiency DNA-based Reverse Genetics Platforms for manufacturing RNA virus products.$279,270
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1279DNATWO, INC.——
1280ASYMMETREX, LLC——
1281FPRT BIO, INC.——
1282ADVANCED VIROLOGY INC.——
1283IMMUNE MODULATORY THERAPIES, LLC——
1284XLOCK BIOSCIENCES, LLC——
1285GENETIC INTELLIGENCE——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.